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Abstract
Background: Poly-ADP-ribosylation, a reversible post-translational modification of primarily chromosomal proteins,
is involved in various cellular and molecular processes including carcinogenesis. ADP-ribose polymer or poly-ADP-
ribose adducts are enzymatically added onto or stripped off the target chromosomal proteins during this
metabolic process. Due to this, the chromatin superstructure is reversibly altered, which significantly influences the
pattern of gene expression. We hypothesize that a decrease in the concentration of total poly-ADP-ribose adducts
of peripheral blood lymphocyte (PBL) proteins strongly correlates with the incidence of human cancer.
Results: Using a novel immunoprobe assay, we show a statistically significant (P ≤ 0.001) reduction (~ 42 to 49%)
in the level of poly-ADP-ribose adducts of PBL proteins of patients with advanced cancers of head & neck (H & N)
region (comprising fourteen distinct cancers at different sites), breast and cervix in comparison to healthy controls.
Conclusions: These findings imply potential utility of the poly-ADP-ribose adducts of PBL proteins as a novel and
general biomarker of human cancers with potentials of significant clinical and epidemiological applications.
Background
Poly-ADP-ribosylation is an enzyme catalyzed reversible
post-translational modification of cellular proteins
[reviewed in [1-5]]. During this process, ADP-ribose
units are transferred onto or stripped off the acceptor or
target proteins. Accordingly, the target protein becomes
poly-ADP-ribosylated or deribosylated, respectively. The
biosynthesis of the homopolymer of ADP-ribose or
poly-ADP-ribose adduct(s) is primarily catalysed by the
enzyme, poly-ADP-ribose polymerase (PARP), which is
ubiquitously present in the nuclei of metabolically active
cells [1,5,6]. The enzyme progressively and sequentially
catalyses transfer of ADP-ribose units derived from the
endogenous nicotinamide adenine dinucleotide (NAD
+)
donors onto acceptor or target proteins creating homo-
polymeric adducts in a variety of linear and branched
architectures. Nuclear proteins, particularly histones, are
the primary targets of ribosylation [3-5]. Poly-ADP-
ribose glycohydrolase (PARG) is the main enzyme
involved in the breakdown of adducts from the protein
[1,3,4]. The build up of the adduct on or its breakdown
from the chromosomal proteins reversibly alters
chromatin superstructure and, thereby, significantly
influences the pattern of gene expression [1-5]. Conse-
quently, status of ribosylation of chromosomal proteins
is intricately involved in carcinogenesis [4,5]. Previous
detailed investigations done in murine model have
shown that the metabolic level of the ADP-ribose
adduct on total cellular proteins is significantly reduced
during different stages of carcinogenesis [7-13]. These
systematic studies have revealed the existence of an
inverse relationship between carcinogenesis and the
total ADP-ribose polymers or poly-ADP-ribose adduct
level measured either in cancerous tissue or in periph-
eral blood lymphocytes (PBL). Therefore, we hypothe-
size that a decreased quantum of the total adduct of
poly-ADP-ribose on human PBL proteins would also
correlate with human cancer. In order to test the
hypothesis, we have detected and quantified the total
concentration of ADP-ribose polymer adducts of PBL
proteins in healthy individuals (controls) and cancer
patients (cases). PBL was chosen since PBL proteins
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cellular proteins of liver, spleen, ascites cells and other
tissues [10]. In addition, a blood based assay of
ADP-ribose polymer adducts is the most convenient
procedure to perform on humans since it is the most
non-invasive medical intervention. An assay using other
tissues or biopsies pose practical problems as obtaining
the tissue usually requires surgical intervention. Further-
more, the immune system of the body resides in the
blood. The PBL are the first responders to foreign inva-
sions across the body. They also communicate with cells
as well as cellular matrices of all tissues/organs of the
body [14]. This circulating tissue, therefore, qualifies to
be the sentinel of the whole body [15]. We have chosen
the PBL for this reason as our aim was to identify and
establish a general biomarker of cancer, which can be
conveniently monitored.
This hypothesis has been tested in total cellular pro-
teins of the PBL of normal human donors (controls)
and in patients (cases) with advanced head & neck (H &
N), breast or cervical cancers using a novel immunop-
robe assay that quantitatively measures the total cellular
poly-ADP-ribose polymer [5,7,8].
Results & Discussion
Blood samples were collected from new cancer patients
(cases), who had not received any treatment so far, as
well as from healthy volunteers (controls) in accordance
with the approvals of Institutional Ethics Committees of
NEHU and BBCI. The cases comprised male as well as
female patients with advanced stages of cancers at 14
different sites of head & neck region (grouped as Ca H
& N), breast and cervix (age range 25-80 years). The
controls consisted of healthy, male and female volun-
teers with no known history of cancer (age range 25-80
years). Analysis of age distribution of controls and cases
was done using unpaired t-test with Welch correction
and c
2 test, which showed that statistically older males
(P ≤ 0.0001), but not females (P = 0.4250), made the
case group (Figure 1 - inset Table).
Overall, the cancer patients (cases) were statistically
older (47.70 years) than the control counterparts (39.90
years) (Figure 1 - inset Table). The PBL protein samples
(500 ng per slot) were prepared from blood samples of
controls (n = 68) and cases (total n = 112). The cases
comprised patients with cancers of 14 different sites
grouped as Ca H & N (total n = 66), Ca breast (n = 22)
or Ca cervix (n = 24). Samples were subjected to quan-
titative detection of poly-ADP-ribose adducts using the
novel slot blot immunoprobe assay followed by densito-
metric analysis as described [7,8]. Figure 1 - a shows a
typical slot blot stained for total proteins using India
ink (left panel) and its immunoprobed replicum (right
panel) for five replicate samples from a control subject
Figure 1 Quantitative assay of ADP-ribose polymer adducts and analysis of controls.( a) A typical set of results of slot blot immunoprobe
assay used in the study. PBL protein (500 ng per slot) samples from a control (A) and a cancer patient (B) were slot blotted on NCM in
replicates of five or more. One NCM blot was stained with India ink for total protein (left panel), which also served as the loading control, and its
replica slot was immunoprobed for total ADP-ribose polymer (right panel). After concentration correction, quantification of total ADP-ribose
polymer of PBL proteins was done as mean net pixel intensity of the immunoprobed slot in arbitrary units (AU). Each sample was independently
slotted thrice (3 sets) making at least 15 replicates for each sample (individual). The mean of all replicates for each sample/individual has been
plotted as a dot (dark green - female (n = 27); light green - male (n = 41)) in the graphs to highlight the observed individual variance (b-d ).
Linear regression of the controls (r
2 = 0.003676, P = 0.6233, n = 68) show that individual value fell within the range of variation (b), which was
nearly the same when viewed in terms of the age of the individual (c). The control values between gender groups (male and female) were
statistically (P = 0.0463) identical (d). The mean age of male cancer patients (cases) was statistically higher than the control while it was
statistically identical in case of females (inset Table).
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Page 2 of 8(A) and a cancer patient (B). The concentration cor-
rected mean net intensity of each control sample has
been plotted as a dot to show the distribution of mea-
sured poly-ADP-ribose adduct levels in relation to sam-
ple number (Figure 1 - b), age of patient (Figure 1 - c)
and gender of patient (Figure 1 - d) highlight the range
of variation in measured control values in arbitrary
units (AU) (mean: 14573 ± 1452 AU; range: 11950 -
17540 AU).
Compared to the control group, the total poly-ADP-
ribose adduct of PBL proteins of H & N cancer patients
showed a statistically significant (P < 0.0001) reduction
in cancers of all 14 sites (Figure 2 - a, inset Table).
The overall reduction was approximately 45% with a
mean of net intensity of 8060 ± 707.10 AU (range of
6324 - 10318 AU). Cancers of all sites in this group
individually (Table 1) as well as collectively (Table 2)
showed significant reduction as revealed by Student’st -
test and ANOVA, respectively. Similarly, there were sig-
nificant reductions in the total poly-ADP-ribose adduct
of PBL proteins in cancers of breast (Figure 2 - b, inset
Table) and cervix (Figure 2 - c, inset Table) in
comparison to all controls (males + female controls
combined) as well as only female controls. The extent of
reduction in the poly-ADP-ribose adduct among the
cases was 47% and 43% for breast and cervical cancers,
respectively, which are statistically highly significant (P <
0.0001, unpaired t-test with Welch’s correction) as
shown in the inset table (Figure 2). These results are in
line with previous studies done in murine model, which
showed negative and statistically significant correlation
between total cellular poly-ADP-ribose adduct and car-
cinogenesis [8-13].
As this report deals with elucidation of a general bio-
marker of cancer, the mechanistic aspects of lowering of
the level of poly-ADP-ribose adduct of cellular proteins
and its likely implications on the biological functions of
chromatin, including gene expression, is not being dis-
cussed here. These aspects have been reviewed in details
recently [5] as well as earlier [4]. It might be prudent to
add that in the our considered opinion, the PBL, being
the first responders of the body to sense metabolic
changes and mount appropriate biological response(s),
are the most appropriate cells to look for the alterations
Figure 2 Quantification of ADP-ribose polymer adducts in cancer patients.( a) The graph shows the levels of ADP-ribose polymer of PBL
proteins of each subject as a dot for cancers of different sites in the head and neck region (grouped as cancer of H & N) as compared to all
controls (dark green - female (n = 27); light green - male (n = 41)). In all, 14 different types of cancers of H & N were examined in this study; for
three such cancers we had only one patient each. Individually all cancers of different sites under H & N category declined significantly below the
control value (see details in Table 1). The results from patients with cancers of breast and cervix have been shown in (b) and (c), respectively.
Since these two cancers exclusively afflict females, the plot shows individual values of total ADP-ribose polymer of PBL proteins for all controls
(males + females) as well as only female controls. In all three categories of cancers, the reduction in the level of total ADP-ribose polymer of PBL
proteins was highly significant (P < 0.0001) when compared with all controls or only female controls (inset Table).
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during carcinogenesis.
The subjects under investigations are likely to be
exposed to different and variable etiological factors.
Etiological factors could influence both measured poly-
ADP-ribose adduct level as well as the course of
carcinogenesis. Therefore, we also analysed the influence
of three most important etiological factors relevant to
the study on poly-ADP-ribose adduct and human can-
cer. The factors are habits of (a) wet variety of betel nut
(BN) chewing - a social etiquette that is strongly asso-
ciated with cancers, especially to cancer of H & N
Table 1 Poly-ADP-ribose adduct levels in controls and individual cancers of H & N
Category/Type/Site of cancer Number
of cases (n)




Control 68 14573 ±1452
All cancer of head and neck (H & N) region 66 8059 ± 304
Cancer of oesophagus 19 8007 ± 463 0.9247 < 0.0001
Cancer of alveolo 6 8173 ± 651 0.9761 < 0.0001
Cancer of pyriform sinus 4 8196 ± 258 0.9759 < 0.0001
Cancer of nasopharynx 10 7890 ± 833 0.9611 < 0.0001
Cancer of larynx 1 7537 NA NA
Cancer of tongue 4 8340 ± 885 0.893 0.002
Cancer of tonsil 5 7879 ± 1081 0.9713 < 0.0001
Cancer of buccal mucosa 3 8172 ± 327 0.9903 < 0.0001
Cancer of pharynx 3 8177 ± 261 0.9870 < 0.0001
Cancer of lip 3 7801 ±906 0.9869 0.0066
Cancer of nasal cavity 2 8554 ± 440 NA NA
Cancer of oral cavity 1 7681 NA NA
Cancer of epiglottis 4 8553 ± 440 0.9849 < 0.0001
Cancer of vocal chord 1 7873 NA NA
Table showing the analysis of unpaired t test with Welch corrections between total poly-ADP-ribose adduct level of PBL proteins (mean ± SD) in control and
each site of cancer of head and neck (H & N) region. The value at each site of cancer was compared to the control separately (NA - not applicable as n was 1
(single case)).
Table 2 ANOVA of poly-ADP-ribose adduct in controls and cancer of H & N region
Category/Type/Site of cancer Number
of cases (n)




Control 68 14573 ± 1452 0.893 <0.0001
Cancers of head & neck region 66 8059 ± 304
Cancer of oesophagus 19 8007 ± 463
Cancer of alveolo 6 8173 ± 651
Cancer of pyriform sinus 4 8196 ± 258
Cancer of nasopharynx 10 7890 ± 833
Cancer of larynx 1 7537
Cancer of tongue 4 8340 ± 885
Cancer of tonsil 5 7879 ± 1081
Cancer of buccal mucosa 3 8172 ± 327
Cancer of pharynx 3 8177 ± 261
Cancer of lip 3 7801 ± 906
Cancer of nasal cavity 2 8554 ± 440
Cancer of oral cavity 1 7681
Cancer of epiglottis 4 8553 ± 440
Cancer of vocal chord 1 7873
Table showing the one-way analysis of variance (ANOVA) between total poly-ADP-ribose adduct of PBL proteins (mean ± SD) of control and cancer of head and
neck (H & N).
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Page 4 of 8[reviewed in [16,17]], (b) alcohol consumption [reviewed
in [18]] and (c) tobacco usage [reviewed in [19,20]].
These three factors did not show any statistically sig-
nificant influence on the level of poly-ADP-ribose
adduct in control subjects as revealed by Spearman rank
correlation and Mann-Whitney rank sum test (Table 3).
However, while BN chewing did not significantly influ-
ence the total poly-ADP-ribose adduct of PBL proteins
in cancer patients (Figure 3 - c), alcohol consumption
(Figure 3 - a) and tobacco usage (Figure 3 - b) were
found to lower the level of total poly-ADP-ribose adduct
of PBL proteins in cancer patients significantly as com-
pared to the patients without these habits (Table 4).
In order to further compare the total poly-ADP-ribose
adduct of PBL proteins in controls and cases, we
matched subjects for age and gender. We obtained 28
controls (11 females and 17 males) and 56 cases (33
females and 23 males) in the age range of 24-65 years
(Figure 3 - d, e and inset Table). Again a statistically
highly significant (P < 0.0001) reduction (~ 47% in
males and ~ 44% in females) in total poly-ADP-ribose
adduct of PBL proteins was observed in cancer patients
when compared with their age and gender adjusted
controls.
Conclusions
In conclusion, our findings reveal statistically highly sig-
nificant negative correlation between total poly-ADP-
ribose adduct of PBL proteins in advance human can-
cers of H & N (14 different types), breast and cervix in
comparison to healthy controls using a novel immunop-
robe assay of poly-ADP-ribose adduct. Based on the pre-
liminary data, we conclude that poly-ADP-ribose adduct
of PBL proteins is a useful and general biomarker of
cancers in humans. Potentially it can be used as a
convenient tool for detection of cancer using the novel
immunoprobe assay. The ease with which the assay
could be performed along with the results presented in
this report support our earlier contention [8,10-13] that
the total poly-ADP-ribose adduct of PBL proteins can
potentially be used as a tool for mass screening of can-
cer. We are aware of the fact that further studies on
patients in early stages of different cancers and patients
undergoing chemo- or radiotherapy, etc. would
strengthen the reported findings.
Methods
Chemicals
All chemicals were of analytical grade and were used
without further purification. All solutions were prepared
in sterile ultrapure (Milli-Q) water. Histopaque-1077,
phenylmethanesulfonyl fluoride (PMSF) and 0.45μ nitro-
cellulose membrane (NCM) were purchased from
Sigma-Aldrich, USA. RPMI-1640 was purchased from
HyClone, Utah, USA and India ink from Rotring Zei-
chentusche Drawing Ink, Hamburg, Germany. Alkaline
phosphatase-conjugated goat anti-rabbit IgG (ALP~IgG)
and 5-bromo-4-chloro-3-indolyl phosphate (BCIP)/nitro-
blue tetrazolium (NBT) solution were purchased from
Bangalore Genei, India. Polyclonal antibody (PAb)
against natural, heterogeneous ADP-ribose polymers of
spleen cells was raised in the laboratory as described
earlier [7,8].
Cancer (case) and control groups of individuals/subjects
The blood samples were collected from new patients
visiting Dr. B. Barooah Cancer Institute (BBCI), Guwa-
hati, India in accordance with the Ethics Committee
approvals. The informed and consenting (signed)
patients, who have not yet been treated for cancer, were
Table 3 Influence of selected etiological factors on poly-ADP-ribose adduct in control subjects
Control subjects Category Number
of cases (n)
Poly-ADP-ribose adduct level (AU)
(Mean ± SD)
P
Gender Male 41 14870 ± 1405 0.0463*
Female 27 14130 ± 1431
Tobacco Yes (+) 9 13879 ± 1617 0.1402
No (-) 59 14605 ± 1418
Alcohol Yes (+) 10 14528 ± 1657 0.9379
No (-) 58 14541 ± 1452
Betel nut Yes (+) 50 14646 ± 1436 0.9839
No (-) 18 14286 ± 1507
Diet Vegetarian 34 14478 ± 1442 0.6194
Non-vegetarian 34 14667 ± 1447
Table showing the effect of selected cancer-relevant etiological factors on the level of total poly-ADP-ribose adduct of PBL proteins (mean ± SD) in the control
subjects. A Mann-Whitney rank sum test was performed to analyze the effect of the etiological factors. None showed any statistically significant influence on the
level of total poly-ADP-ribose adduct in PBL except a weakly significant effect of gender; the female control subjects had a slightly lower mean value of poly-
ADP-ribose adducts than the male subjects (* - statistically significant).
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(stage III/IV) of different sites in the head & neck (H &
N) region, breast and cervix (age range 25-80 years).
Detailed information on each individual patient as well
as control was recorded, which included age, gender,
and other personal data besides family history, history
and pattern of betel nut chewing, alcohol consumption
and tobacco use, nutritional history, medical history,
and radiation exposure history, etc. Different cancers of
the H & N included cancer of the oesophagus, tongue,
tonsil, nasopharynx, pharynx, buccal mucosa, alveolus,
pyriform sinus, larynx, lip, nasal cavity, epiglottis, oral
cavity and vocal cord. The control group consisted of
normal healthy volunteers with no known history of
cancer (age range 25-80 years).
Isolation of peripheral blood lymphocyte (PBL) and
preparation of samples for immunoprobe assay
Blood was collected in a heparinized tube from the sub-
ject. PBL was isolated from the collected blood using
Figure 3 Effects of selected etiological factors on the cellular level of ADP-ribose polymer adducts in cancer patients.( a-c ) The graphs
show the effect of three main cancer related etiological factors on the total ADP-ribose polymer of PBL proteins in cancer patients following
Spearman rank correlation test and Mann-Whitney rank sum test. The value for each patient is shown as a dot. Cancer patients exposed to
alcohol recorded a statistically highly significant (P < 0.0001) reduction in the mean value of ADP-ribose polymer of PBL proteins as compared to
patients not exposed to alcohol (a). Similarly, patients exposed to tobacco also recorded significantly (P = 0.0033) lower mean ADP-ribose
polymer value than those not exposed to tobacco (b). In contrast, the wet variety of betel nut chewing habit of cancer patient did not seem to
significantly (P = 0.0935) lower the level of ADP-ribose polymer when compared to the non-chewers (c). The values of total ADP-ribose polymer
of PBL proteins for the age- and gender-matched (male - d; female - e) controls and cancer patients were also plotted. As is evident, the
reductions in the level of ADP-ribose polymer of PBL proteins is highly significant (inset Table) suggesting that measure of ADP-ribose polymer
of PBL protein is a general biomarker of cancer in humans.
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Page 6 of 8Histopaque separation medium as described [10].
Briefly, equal volumes of heparinized blood and
balanced salt solution (BSS; pH 7.6 containing 5.5 mM
anhydrous D-glucose, 5 mM CaCl2,0 . 0 9 8m MM g C l 2,
5.4 mM KCl, 0.145 M Tris and 0.14 M NaCl) were
mixed and layered over Histopaque. It was centrifuged
at 400 × g for 40 min at room temperature (RT). The
clear lymphocyte layer at the interface was drawn using
a Pasteur pipette and washed twice with 3 volumes of
BSS at 100 × g for 10 min at RT. The final pellet was
suspended in 1 ml of RPMI-1640 and stored at -80°C
until further use.
To prepare the whole homogenate (WH) of the isolated
PBL, the lymphocytes in RPMI-1640 were pelleted down
by centrifugation at 250 × g for 5 min at RT and washed
with ice cold phosphate buffered saline (PBS; 3.2 mM
Na2HPO4,0 . 5m MK H 2PO4, 1.3 mM KCl and 135 mM
NaCl, pH 7.4) at 200 × g for 10 min at 4°C. One ml of ice
cold lysis buffer (20 mM Tris-Cl, pH 8, 10 mM NaCl,
0.5% Triton X-100, 5 mM EDTA and 3 mM MgCl2)w a s
added to the pellet, mixed gently, incubated on ice for 30
min, and the lysate was centrifuged at 5000 × g for 10
min at 4°C. The protein content of the resulting superna-
tant, which was used for the assay of poly-ADP-ribose
adducts, was estimated by Bradford method using bovine
serum albumin (BSA) as a standard. The supernatant was
stored at -20°C, whenever required, until further use.
Immunoprobe assay of poly-ADP-ribose
The assay for total poly-ADP-ribose adduct of the WH
proteins of PBL was done by a novel, slot blot immunop-
robe assay developed by us, which employs PAb raised
against natural, heterogeneous ADP-ribose polymers of
mouse spleen cells. The novelty of the assay lies in the
fact that it quantitatively measures the total cellular poly-
ADP-ribose adducts irrespective of the target protein to
which it may be attached. Therefore, the assay reveals the
true metabolic level of total cellular poly-ADP-ribose.
The assay has been described in details earlier [7,8].
Briefly, slot-blotting was carried out using a Bio-dot
microfiltration apparatus (Bio-Rad). Samples were heat
inactivated by dipping the sample tubes in a boiling
water bath for 5 min. One hundred μl of sample contain-
ing 500 ng protein was loaded in each well and slot
blotted on NCM under slow and regulated vacuum. The
NCM was then immunoprobed for total poly-ADP-ribose
adduct of PBL proteins as well as stained with India ink
for total cellular proteins as previously described [8].
Immunoprobe assay involved blocking of the NCM by a
5% non-fat dry milk in tris buffered saline (TBS; 20 mM
Tris-Cl, pH 7.5, 500 mM NaCl) at RT, incubation in the
primary PAb (1:1000) for 1 h at 37°C and incubation in
the secondary antibody, ALP~IgG (1:10000), for 1 h at
37°C. Each of these steps was followed by washing twice
in TBS and TTBS (TBS containing 0.05% Tween 20) for
5 min each at RT. The color on the NCM was developed
by incubating the NCM in 5-bromo-4-chloro-3-indolyl
phosphate (BCIP)/nitroblue tetrazolium (NBT) color
developer (5-10 min) at RT.
Quantitative image analysis
Immunoprobed and India ink stained slot blots were
scanned (HP Scanjet 7000C) and digitized. The densito-
metric analysis was done using KDS-ID software
(Kodak). Each sample was slot blotted in replicates of
five and analysed. The results have been expressed as
the mean net pixel intensity of bands (± SD) in arbitrary
units (AU) after concentration correction.
Table 4 Influence of selected etiological factors on poly-ADP-ribose adduct in cancer patients
Cancer patients (Cases) Category Number
of cases (n)
Poly-ADP-ribose adduct level (AU)
(Mean ± SD)
P
Gender Male 49 8161 ± 643.6 0.0673
Female 63 7982 ± 748.2
Tobacco Yes (+) 48 7840 ± 543 0.0033*
No (-) 64 8232 ± 771
Alcohol Yes (+) 34 7699 ± 518.1 0.0001*
No (-) 78 8223 ± 718.9
Betel nut Yes (+) 68 7963 ± 628.3 0.0935
No (-) 44 8220 ± 791.9
Diet Yes (+) 56 8110 ± 707.8 0.6902
No (-) 56 8010 ± 709.2
Table showing the effect of selected cancer-relevant etiological factors on the level of total poly-ADP-ribose adduct of PBL proteins (mean ± SD) in cancer
patients (cases). A Mann-Whitney rank sum test was performed to analyze the effect of the etiological factors. Highly or moderately significant reductions of the
total poly-ADP-ribose adduct of PBL proteins were observed in patients exposed to alcohol (compared to alcohol minus patients) and tobacco (comparedt o
tobacco minus patients), respectively. Interestingly, gender, BN and diet did not seem to influence the poly-ADP-ribose adduct level in these patients (* -
statistically significant).
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An unpaired t-test with Welch’sc o r r e c t i o nw a su s e dt o
analyze the distribution of mean age. A linear regression
analysis with 95% confidence bands was performed to
examine the poly-ADP-ribose adduct level within the
control group. A One way ANOVA was used to com-
pare the poly-ADP-ribose adduct levels between con-
trols and patients with cancers of the H & N region. An
unpaired t-test with Welch’s correction was used to
compare the poly-ADP-ribose adduct levels between
controls and patients with cancers of the breast and cer-
vix. Spearman rank correlation test was performed to
evaluate the correlation between poly-ADP-ribose
adduct and age. c
2 test was used to examine the influ-
ence of various factors (age, gender, betel nut, alcohol,
tobacco consumptions, etc.) in each of the groups. A
Fisher’s exact test was applied when necessary. The ana-
lysis of influence of different etiological factors in the
controls and cases was performed using Mann-Whitney
rank sum test. Mann-Whitney rank sum test was also
performed to compare the poly-ADP-ribose adduct
levels in control and cases matched for age and gender.
P value of < 0.05 was taken as statistically significant. In
the entire test a two-tailed P value was used.
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